ApconiX was featured November 19th 2015 in a BBC News NorthWest item as one of the success stories of the Northern Power House (click here for video).
BBC political correspondent Arif Ansari was interested to hear how we assembled a team of the best expert science professionals all of whom want to stay in the North West and are leaving AstraZeneca with a combined 150+ years of drug development experience. As I explained to Arif, most new medicines fail due to safety/toxicity; ApconiX will tackle this issue by bringing world-class nonclinical safety expertise to biotech, biopharma and academia.
Even though we only began trading this year, ApconiX has its first handful of contracts working with a range of partners from small to large companies, charities and government. We have the first money in too! But the next 6 months is a critical time for us as we commit to the expense of our own dedicated lab space and specialised equipment.
Importantly, AstraZeneca and the Alderley Park BioHub have partnered us every step of the way as we have ventured out on our own, and they have been invaluable in our journey.